Explanipedia

Current clinical practices and challenges in molecular testing: a GOAL Consortium Hematopathology Working Group report Open

Thomas D. Lee, Dara L. Aisner, Marjorie David, Celeste Eno, Jeffrey Gagan , et al. · 2023

Medicine Biology Computer science

While molecular testing of hematologic malignancies is now standard of care, there is variability in practice and testing capabilities between different academic laboratories, with common questions arising on how to best meet clinical expe…

Complex/cryptic EWSR1::FLI1/ERG Gene Fusions and 1q Jumping Translocation in Pediatric Ewing Sarcomas Open

Ying Zou, Laura Morsberger, Melanie Hardy, Jen Ghabrial, Victoria Stinnett , et al. · 2023

Biology

Ewing sarcomas (ES) are rare small round cell sarcomas often affecting children and characterized by gene fusions involving one member of the FET family of genes (usually EWSR1) and a member of the ETS family of transcription factors (usua…

Table S4 from Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics Open

Deyin Xing, Gang Zheng, Aparna Pallavajjala, J. Kenneth Schoolmeester, Yuehua Liu , et al. · 2023

Biology Computer science

Supplementary Table S4

Table S1 from Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics Open

Deyin Xing, Gang Zheng, Aparna Pallavajjala, J. Kenneth Schoolmeester, Yuehua Liu , et al. · 2023

Biology Computer science

Supplementary Table S1

Supplementary Data from Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics Open

Deyin Xing, Gang Zheng, Aparna Pallavajjala, J. Kenneth Schoolmeester, Yuehua Liu , et al. · 2023

Biology History Computer science

Supplementary Table and Figure legends

Supplemental Methods, Figures and Tables from Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer Open

Vincent P. Groot, Stacy Mosier, Ammar A. Javed, Jonathan A. Teinor, Georgios Gemenetzis , et al. · 2023

Medicine Biology

Supplemental Methods, Figures and Tables

Figure S4 from Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics Open

Deyin Xing, Gang Zheng, Aparna Pallavajjala, J. Kenneth Schoolmeester, Yuehua Liu , et al. · 2023

Biology Medicine

Supplementary Figure S4

Table S3 from Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics Open

Deyin Xing, Gang Zheng, Aparna Pallavajjala, J. Kenneth Schoolmeester, Yuehua Liu , et al. · 2023

Biology Computer science

Supplementary Table S3

Supplemental Methods, Figures and Tables from Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer Open

Vincent P. Groot, Stacy Mosier, Ammar A. Javed, Jonathan A. Teinor, Georgios Gemenetzis , et al. · 2023

Medicine Biology

Supplemental Methods, Figures and Tables

Table S3 from Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics Open

Deyin Xing, Gang Zheng, Aparna Pallavajjala, J. Kenneth Schoolmeester, Yuehua Liu , et al. · 2023

Biology Medicine Computer science

Supplementary Table S3

Tables S2A and S2B from Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics Open

Deyin Xing, Gang Zheng, Aparna Pallavajjala, J. Kenneth Schoolmeester, Yuehua Liu , et al. · 2023

Biology

Supplementary Tables S2A and S2B

Data from Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics Open

Deyin Xing, Gang Zheng, Aparna Pallavajjala, J. Kenneth Schoolmeester, Yuehua Liu , et al. · 2023

Biology

Purpose:Choriocarcinoma is most commonly gestational (androgenetic or biparental) but can be of germ cell origin or can develop as a component of a somatic neoplasm (genetically related to the patient). The latter type are aggressive neopl…

Figure S1 from Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics Open

Deyin Xing, Gang Zheng, Aparna Pallavajjala, J. Kenneth Schoolmeester, Yuehua Liu , et al. · 2023

Biology Medicine

Supplementary Figure S1

Table S5 from Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer Open

Vincent P. Groot, Stacy Mosier, Ammar A. Javed, Jonathan A. Teinor, Georgios Gemenetzis , et al. · 2023

Medicine Biology Computer science

Serial Dilution Data

Figure S2 from Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics Open

Deyin Xing, Gang Zheng, Aparna Pallavajjala, J. Kenneth Schoolmeester, Yuehua Liu , et al. · 2023

Biology

Supplementary Figure S2

Data from Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics Open

Deyin Xing, Gang Zheng, Aparna Pallavajjala, J. Kenneth Schoolmeester, Yuehua Liu , et al. · 2023

Biology

Purpose:Choriocarcinoma is most commonly gestational (androgenetic or biparental) but can be of germ cell origin or can develop as a component of a somatic neoplasm (genetically related to the patient). The latter type are aggressive neopl…

Data from Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer Open

Vincent P. Groot, Stacy Mosier, Ammar A. Javed, Jonathan A. Teinor, Georgios Gemenetzis , et al. · 2023

Medicine Biology

Purpose:In research settings, circulating tumor DNA (ctDNA) shows promise as a tumor-specific biomarker for pancreatic ductal adenocarcinoma (PDAC). This study aims to perform analytical and clinical validation of a KRAS ctDNA assay in a C…

Figure S4 from Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics Open

Deyin Xing, Gang Zheng, Aparna Pallavajjala, J. Kenneth Schoolmeester, Yuehua Liu , et al. · 2023

Biology

Supplementary Figure S4

Data from Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer Open

Vincent P. Groot, Stacy Mosier, Ammar A. Javed, Jonathan A. Teinor, Georgios Gemenetzis , et al. · 2023

Medicine Biology

Purpose:In research settings, circulating tumor DNA (ctDNA) shows promise as a tumor-specific biomarker for pancreatic ductal adenocarcinoma (PDAC). This study aims to perform analytical and clinical validation of a KRAS ctDNA assay in a C…

Figure S1 from Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics Open

Deyin Xing, Gang Zheng, Aparna Pallavajjala, J. Kenneth Schoolmeester, Yuehua Liu , et al. · 2023

Biology

Supplementary Figure S1

Table S5 from Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer Open

Vincent P. Groot, Stacy Mosier, Ammar A. Javed, Jonathan A. Teinor, Georgios Gemenetzis , et al. · 2023

Medicine Biology Computer science

Serial Dilution Data

Figure S3 from Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics Open

Deyin Xing, Gang Zheng, Aparna Pallavajjala, J. Kenneth Schoolmeester, Yuehua Liu , et al. · 2023

Biology

Supplementary Figure S3

Figure S3 from Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics Open

Deyin Xing, Gang Zheng, Aparna Pallavajjala, J. Kenneth Schoolmeester, Yuehua Liu , et al. · 2023

Biology Medicine

Supplementary Figure S3

Table S4 from Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics Open

Deyin Xing, Gang Zheng, Aparna Pallavajjala, J. Kenneth Schoolmeester, Yuehua Liu , et al. · 2023

Biology Medicine Computer science

Supplementary Table S4

Figure S2 from Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics Open

Deyin Xing, Gang Zheng, Aparna Pallavajjala, J. Kenneth Schoolmeester, Yuehua Liu , et al. · 2023

Biology

Supplementary Figure S2

Figure S5 from Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics Open

Deyin Xing, Gang Zheng, Aparna Pallavajjala, J. Kenneth Schoolmeester, Yuehua Liu , et al. · 2023

Biology Medicine

Supplementary Figure S5

Supplementary Data from Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics Open

Deyin Xing, Gang Zheng, Aparna Pallavajjala, J. Kenneth Schoolmeester, Yuehua Liu , et al. · 2023

Biology Computer science

Supplementary Table and Figure legends

Figure S5 from Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics Open

Deyin Xing, Gang Zheng, Aparna Pallavajjala, J. Kenneth Schoolmeester, Yuehua Liu , et al. · 2023

Biology

Supplementary Figure S5

Table S1 from Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics Open

Deyin Xing, Gang Zheng, Aparna Pallavajjala, J. Kenneth Schoolmeester, Yuehua Liu , et al. · 2023

Biology Computer science

Supplementary Table S1

Lisa Haley YOU? Author Swipe